Overview
HBAR and INJ rarely move in perfect sync. Today’s print ($0.069850/$5.15) and 24h leaders (Injective) help frame which side currently carries relative strength.
Quick winners
Full comparison
| Metric | HBAR | INJ |
|---|---|---|
| Price | $0.069850 | $5.15 |
| Market Cap | $3.06B | $490.41M |
| FDV | — | — |
| Volume 24h | $3.17M | $2.50M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 29.00 | 98.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +3.64% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | HBAR | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +0.93% | +5.19% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | HBAR | INJ |
|---|---|---|
| RSI | 49.02 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 67.35 | 0.29 |
| ADX | 21.33 | 12.19 |
| Support | 1,827.82 | 4.91 |
| Resistance | 1,960.30 | 5.47 |
| Trend | bearish | neutral |
| Momentum | 63.00 | — |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight bearish conditions on HBAR and neutral on INJ. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | HBAR | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | — | 0.00 |
| Github activity | — | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
HBAR
Injective
Pros and cons
Pros of HBAR
- HBAR typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Market-cap scale on HBAR may dampen some idiosyncratic shocks versus smaller peers.
- HBAR has an established coin page footprint on PEPS for continuous monitoring.
Cons of HBAR
- Indicator stacks on HBAR may stay stretched longer than expected in strong trends.
- Regulatory or macro headlines can hit HBAR harder simply because it is more visible.
Pros of Injective
- If technical momentum aligns, Injective may outperform on medium-term windows.
- Injective can offer higher relative beta when market attention rotates toward its niche.
- Active volume bursts on INJ sometimes precede sharper tactical moves.
Cons of Injective
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
- Trend failures on Injective often travel faster than on more established assets.
- Relative underperformance versus HBAR can persist through entire market regimes.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put HBAR at $0.069850 and Injective at $5.15. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, HBAR or Injective?
“Better” depends on horizon and risk. HBAR leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, HBAR or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both HBAR and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. HBAR currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.